Order Article Reprints

Shimizu T, Miyake M, Nishimura N, Inoue K, Fujii K, Iemura Y, Ichikawa K, Omori C, Tomizawa M, Maesaka F, et al. Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study. Cancers. 2022; 14(7):1735. https://doi.org/10.3390/cancers14071735

Shimizu, Takuto, Makito Miyake, Nobutaka Nishimura, Kuniaki Inoue, Koyo Fujii, Yusuke Iemura, Kazuki Ichikawa, Chihiro Omori, Mitsuru Tomizawa, Fumisato Maesaka, and et al. 2022. "Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study" Cancers 14, no. 7: 1735. https://doi.org/10.3390/cancers14071735

Shimizu, T., Miyake, M., Nishimura, N., Inoue, K., Fujii, K., Iemura, Y., Ichikawa, K., Omori, C., Tomizawa, M., Maesaka, F., Oda, Y., Miyamoto, T., Sakamoto, K., Kiba, K., Tanaka, M., Oyama, N., Okajima, E., Fujimoto, K., Hori, S., ... Fujimoto, K., on behalf of the Nara Urological Research and Treatment Group †. (2022). Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study. Cancers, 14(7), 1735. https://doi.org/10.3390/cancers14071735